Package 60290-060-02

{"route": ["ORAL"], "spl_id": "482c3fad-fac0-fa00-e063-6394a90a4b75", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0360290059011", "0360290060017", "0360290058014"], "unii": ["33CM23913M"], "rxcui": ["199378", "402505", "402506"], "spl_set_id": ["48080efd-1781-4585-83f8-c43957ac63b3"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Umedica Laboratories USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-060-01)", "package_ndc": "60290-060-01", "marketing_start_date": "20220820"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-060-02)", "package_ndc": "60290-060-02", "marketing_start_date": "20220820"}], "brand_name": "Carbamazepine", "product_id": "60290-060_482c3fad-fac0-fa00-e063-6394a90a4b75", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "60290-060", "generic_name": "Carbamazepine", "labeler_name": "Umedica Laboratories USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "400 mg/1"}], "application_number": "ANDA216594", "marketing_category": "ANDA", "marketing_start_date": "20220820", "listing_expiration_date": "20271231"}